{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:24:18Z","timestamp":1791188658713,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.bcp.2009.05.035","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T07:14:39Z","timestamp":1244618079000},"page":"1279-1288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Drug discovery targeting epigenetic codes: The great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis"],"prefix":"10.1016","volume":"78","author":[{"given":"Motoko","family":"Unoki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Mousli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2009.05.035_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nature07249","article-title":"Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism","volume":"455","author":"Arita","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.05.035_bib2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nature07280","article-title":"The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix","volume":"455","author":"Hashimoto","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.05.035_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature07273","article-title":"Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1","volume":"455","author":"Avvakumov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.05.035_bib4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nature06397","article-title":"The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA","volume":"450","author":"Sharif","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.05.035_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1356-9597.2004.00710.x","article-title":"Down-regulation of nuclear protein ICBP90 by p53\/p21Cip1\/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1\/S transition","volume":"9","author":"Arima","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.bcp.2009.05.035_bib6","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1462-5822.2007.01093.x","article-title":"Toxoplasma gondii exploits UHRF1 and induces host cell cycle arrest at G2 to enable its proliferation","volume":"10","author":"Brunet","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.bcp.2009.05.035_bib7","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1091\/mbc.e05-03-0194","article-title":"Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth","volume":"16","author":"Jenkins","year":"2005","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.bcp.2009.05.035_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/sj.bjc.6601068","article-title":"ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells","volume":"89","author":"Mousli","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bcp.2009.05.035_bib9","doi-asserted-by":"crossref","first-page":"7601","DOI":"10.1038\/sj.onc.1208053","article-title":"ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain","volume":"23","author":"Unoki","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2009.05.035_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molbrainres.2005.06.015","article-title":"Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis","volume":"140","author":"Oba-Shinjo","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bcp.2009.05.035_bib11","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1053\/j.gastro.2005.08.012","article-title":"Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma","volume":"129","author":"Crnogorac-Jurcevic","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1016\/j.bcp.2009.05.035_bib12","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3816\/CLC.2008.s.004","article-title":"Early clinical trial experience with vaccine therapies in non-small-cell lung cancer","volume":"9","author":"Ho","year":"2008","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.bcp.2009.05.035_bib13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1128\/MCB.01598-07","article-title":"ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation","volume":"28","author":"Karagianni","year":"2008","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2009.05.035_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/nar\/gkn961","article-title":"UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells","volume":"37","author":"Kim","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2009.05.035_bib15","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.onc.1210855","article-title":"The interaction of the SRA domain of ICBP90 with a novel domain of DNMT1 is involved in the regulation of VEGF gene expression","volume":"27","author":"Achour","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2009.05.035_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.biolcel.2004.06.003","article-title":"Heterochromatin structure and function","volume":"96","author":"Dillon","year":"2004","journal-title":"Biol Cell"},{"key":"10.1016\/j.bcp.2009.05.035_bib17","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1128\/MCB.24.6.2526-2535.2004","article-title":"Np95 is a histone-binding protein endowed with ubiquitin ligase activity","volume":"24","author":"Citterio","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2009.05.035_bib18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2008.02.014","article-title":"Histone ubiquitination: triggering gene activity","volume":"29","author":"Weake","year":"2008","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2009.05.035_bib19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00018-008-7324-y","article-title":"Methyl-CpG binding proteins: specialized transcriptional repressors or structural components of chromatin?","volume":"65","author":"Clouaire","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2009.05.035_bib20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pharmthera.2007.06.003","article-title":"The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future?","volume":"115","author":"Bronner","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2009.05.035_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0014-5793(03)01495-9","article-title":"NIRF is a ubiquitin ligase that is capable of ubiquitinating PCNP, a PEST-containing nuclear protein","volume":"557","author":"Mori","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2009.05.035_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1432-1327.2001.01869.x","article-title":"Methyl-CpG-binding proteins. Targeting specific gene repression","volume":"268","author":"Ballestar","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2009.05.035_bib23","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1093\/nar\/gkf398","article-title":"The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides","volume":"30","author":"Daniel","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2009.05.035_bib24","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1074\/jbc.M210256200","article-title":"The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation","volume":"278","author":"Fuks","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.05.035_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.molcel.2004.06.043","article-title":"Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly","volume":"15","author":"Sarraf","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2009.05.035_bib26","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/nar\/gkg332","article-title":"The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase","volume":"31","author":"Fuks","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bcp.2009.05.035_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1383-5742(00)00015-6","article-title":"Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens","volume":"462","author":"Hussain","year":"2000","journal-title":"Mutat Res"},{"key":"10.1016\/j.bcp.2009.05.035_bib28","first-page":"797","article-title":"Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis","volume":"25","author":"Nishidate","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.bcp.2009.05.035_bib29","doi-asserted-by":"crossref","unstructured":"Unoki M, Kelly JD, Neal DE, Ponder BAJ, Nakamura Y, Hamamoto R. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer, in press. Online on Jun 2, 2009. [Epub ahead of print].","DOI":"10.1038\/sj.bjc.6605123"},{"key":"10.1016\/j.bcp.2009.05.035_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.humpath.2005.07.016","article-title":"Cell cycle and\/or proliferation markers: what is the best method to discriminate cervical high-grade lesions?","volume":"36","author":"Lorenzato","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.bcp.2009.05.035_bib31","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1593\/neo.07112","article-title":"Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles","volume":"9","author":"Rhodes","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.bcp.2009.05.035_bib32","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0006-291X(02)00890-2","article-title":"NIRF, a novel RING finger protein, is involved in cell-cycle regulation","volume":"296","author":"Mori","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2009.05.035_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bbrc.2004.04.190","article-title":"NIRF induces G1 arrest and associates with Cdk2","volume":"319","author":"Li","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2009.05.035_bib34","first-page":"572","article-title":"Advances in the development of siRNA-based therapeutics for cancer","volume":"11","author":"Shen","year":"2008","journal-title":"IDrugs"},{"key":"10.1016\/j.bcp.2009.05.035_bib35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pharmthera.2005.03.004","article-title":"RNA interference: from gene silencing to gene-specific therapeutics","volume":"107","author":"Leung","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bcp.2009.05.035_bib36","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.0509166103","article-title":"Targeting AMAP1 and cortactin binding bearing an atypical src homology 3\/proline interface for prevention of breast cancer invasion and metastasis","volume":"103","author":"Hashimoto","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bcp.2009.05.035_bib37","first-page":"121","article-title":"ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIalpha expression","volume":"60","author":"Hopfner","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2009.05.035_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00001432-199708000-00006","article-title":"Toxoplasmosis in immunocompromised patients","volume":"10","author":"Hollman","year":"1997","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bcp.2009.05.035_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijpara.2003.11.009","article-title":"Mechanisms underlying the manipulation of host apoptotic pathways by Toxoplasma gondii","volume":"34","author":"Sinai","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bcp.2009.05.035_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0166-6851(86)90101-5","article-title":"Interferon-gamma suppresses the growth of Toxoplasma gondii in human fibroblasts through starvation for tryptophan","volume":"20","author":"Pfefferkorn","year":"1986","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bcp.2009.05.035_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijpara.2003.12.001","article-title":"Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation","volume":"34","author":"Fox","year":"2004","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bcp.2009.05.035_bib42","doi-asserted-by":"crossref","first-page":"31221","DOI":"10.1074\/jbc.M404232200","article-title":"Purine salvage pathways in the apicomplexan parasite Toxoplasma gondii","volume":"279","author":"Chaudhary","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2009.05.035_bib43","first-page":"55","article-title":"New insights in toxoplasmosis immunology during pregnancy. Perspective for vaccine prevention","volume":"50","author":"Pfaff","year":"2008","journal-title":"Parassitologia"},{"key":"10.1016\/j.bcp.2009.05.035_bib44","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bcp.2009.05.035_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bcp.2009.05.035_bib46","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/schbul\/sbm009","article-title":"Early infections of Toxoplasma gondii and the later development of schizophrenia","volume":"33","author":"Mortensen","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.bcp.2009.05.035_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1040838","article-title":"Neurologic manifestations of toxoplasmosis in AIDS","volume":"19","author":"Cohen","year":"1999","journal-title":"Semin Neurol"},{"key":"10.1016\/j.bcp.2009.05.035_bib48","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1462-5822.2008.01117.x","article-title":"Infection with Toxoplasma gondii results in dysregulation of the host cell cycle","volume":"10","author":"Molestina","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.bcp.2009.05.035_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.182.1.489","article-title":"Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation","volume":"182","author":"Leng","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.05.035_bib50","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1111\/j.1742-4658.2007.06045.x","article-title":"Cell cycle-dependent transcription of cyclin B2 is influenced by DNA methylation but is independent of methylation in the CDE and CHR elements","volume":"274","author":"Tschop","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.bcp.2009.05.035_bib51","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00018-008-7556-x","article-title":"Host cell manipulation by the human pathogen Toxoplasma gondii","volume":"65","author":"Laliberte","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2009.05.035_bib52","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1242\/jcs.114.19.3495","article-title":"Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression","volume":"114","author":"Goebel","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2009.05.035_bib53","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1242\/jcs.02934","article-title":"Toxoplasma gondii triggers Gi-dependent PI 3-kinase signaling required for inhibition of host cell apoptosis","volume":"119","author":"Kim","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.bcp.2009.05.035_bib54","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1462-5822.2004.00463.x","article-title":"Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha","volume":"7","author":"Molestina","year":"2005","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.bcp.2009.05.035_bib55","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.174.6.3148","article-title":"IL-10-independent STAT3 activation by Toxoplasma gondii mediates suppression of IL-12 and TNF-alpha in host macrophages","volume":"174","author":"Butcher","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2009.05.035_bib56","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1550-7408.2008.00345.x","article-title":"The history of Toxoplasma gondii\u2014the first 100 years","volume":"55","author":"Dubey","year":"2008","journal-title":"J Eukaryot Microbiol"},{"key":"10.1016\/j.bcp.2009.05.035_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molbiopara.2008.11.014","article-title":"Induction of mitotic S-phase of host and neighboring cells by Toxoplasma gondii enhances parasite invasion","volume":"164","author":"Lavine","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.bcp.2009.05.035_bib58","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1128\/AAC.42.8.2036","article-title":"Paclitaxel arrests growth of intracellular Toxoplasma gondii","volume":"42","author":"Estes","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bcp.2009.05.035_bib59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cell.2006.01.056","article-title":"Toxoplasma gondii sequesters lysosomes from mammalian hosts in the vacuolar space","volume":"125","author":"Coppens","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2009.05.035_bib60","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2009.05.035_bib61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/597478","article-title":"Cytokine profiles in toxoplasmic and viral uveitis","volume":"199","author":"Lahmar","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bcp.2009.05.035_bib62","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00006982-200408000-00039","article-title":"Intravitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization","volume":"24","author":"Tolentino","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.bcp.2009.05.035_bib63","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.1038\/sj.onc.1208878","article-title":"The retinoblastoma gene and its product are targeted by ICBP90: a key mechanism in the G1\/S transition during the cell cycle","volume":"24","author":"Jeanblanc","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2009.05.035_bib64","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1126\/science.1147939","article-title":"Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells","volume":"317","author":"Bostick","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.bcp.2009.05.035_bib65","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bbrc.2008.07.146","article-title":"McPherson JP. Interplay between Np95 and Eme1 in the DNA damage response","volume":"375","author":"Mistry","year":"2008","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209004432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295209004432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:50:13Z","timestamp":1757767813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295209004432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0006295209004432"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2009.05.035","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug discovery targeting epigenetic codes: The great potential of UHRF1, which links DNA methylation and histone modifications, as a drug target in cancers and toxoplasmosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2009.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}